secwatch.observer — SEC 8-K summary
======================================

Issuer:     SeaStar Medical Holding Corp (ICU)
CIK:        0001831868
Form:       8-K
Filed at:   2024-12-19T23:59:59+00:00
Accession:  0000950170-24-138428
Event type: litigation
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

SeaStar Medical faces derivative lawsuit over alleged false FDA approval statements
--------------------------------------------------------------------------------

- Filed Dec 13, 2024 in US District Court for Colorado by shareholder Jose Lazo.
- Defendants include CEO Eric Schlorff, former CFO, and certain current/former directors.
- Alleges false/misleading statements about FDA prospects for Selective Cytopheretic Device and deficient internal controls.
- Claims violations of Exchange Act Sections 14(a), 10(b), 21D, plus breach of fiduciary duty and unjust enrichment.
- Seeks damages, restitution, and injunctive relief; substantially similar to a prior class action disclosed July 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831868/000095017024138428/0000950170-24-138428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831868/000095017024138428/icu-20241213.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-138428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer